1. Home
  2. TSLX vs AMRX Comparison

TSLX vs AMRX Comparison

Compare TSLX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSLX
  • AMRX
  • Stock Information
  • Founded
  • TSLX 2010
  • AMRX 2002
  • Country
  • TSLX United States
  • AMRX United States
  • Employees
  • TSLX N/A
  • AMRX N/A
  • Industry
  • TSLX Investment Managers
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSLX Finance
  • AMRX Health Care
  • Exchange
  • TSLX Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • TSLX 2.1B
  • AMRX 2.5B
  • IPO Year
  • TSLX 2014
  • AMRX N/A
  • Fundamental
  • Price
  • TSLX $24.10
  • AMRX $8.22
  • Analyst Decision
  • TSLX Strong Buy
  • AMRX Strong Buy
  • Analyst Count
  • TSLX 8
  • AMRX 4
  • Target Price
  • TSLX $22.69
  • AMRX $11.50
  • AVG Volume (30 Days)
  • TSLX 598.4K
  • AMRX 1.9M
  • Earning Date
  • TSLX 07-30-2025
  • AMRX 08-08-2025
  • Dividend Yield
  • TSLX 8.54%
  • AMRX N/A
  • EPS Growth
  • TSLX N/A
  • AMRX N/A
  • EPS
  • TSLX 1.89
  • AMRX N/A
  • Revenue
  • TSLX $481,092,000.00
  • AMRX $2,830,186,000.00
  • Revenue This Year
  • TSLX N/A
  • AMRX $9.84
  • Revenue Next Year
  • TSLX N/A
  • AMRX $7.33
  • P/E Ratio
  • TSLX $12.90
  • AMRX N/A
  • Revenue Growth
  • TSLX 4.73
  • AMRX 13.42
  • 52 Week Low
  • TSLX $18.58
  • AMRX $6.50
  • 52 Week High
  • TSLX $24.42
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • TSLX 71.44
  • AMRX 66.64
  • Support Level
  • TSLX $23.67
  • AMRX $8.05
  • Resistance Level
  • TSLX $23.98
  • AMRX $8.24
  • Average True Range (ATR)
  • TSLX 0.39
  • AMRX 0.23
  • MACD
  • TSLX 0.06
  • AMRX 0.04
  • Stochastic Oscillator
  • TSLX 97.46
  • AMRX 94.81

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: